The Synedica Retatrutide 40mg + GLOW Skin 112mg Bundle brings together two Synedica formulations presented in pen format for laboratory research.

Bundle Includes

1 × Synedica Retatrutide 40mg Pen

The product packaging identifies Retatrutide as a triple agonist of GLP-1, GIP and glucagon receptors.

The packaging displays a total labelled content of 40mg, with 4 × 10mg doses, and states that the box contains one pen, 12 disposable needles, and one instruction book.

1 × Synedica GLOW Skin 112mg Pen

The GLOW Skin formulation contains:

• GHK-Cu — 80mg
• BPC-157 — 16mg
• TB-500 — 16mg

The packaging displays a total labelled content of 112mg and states that the box contains one pen, 12 disposable needles, and one instruction book.

Combined Bundle Content

• Synedica Retatrutide — 40mg
• Synedica GLOW Skin — 112mg
• 152mg combined labelled content

Both products are presented in pen format.

Key Features

• Synedica research bundle
• 1 × Retatrutide 40mg Pen
• 1 × GLOW Skin 112mg Pen
• 152mg combined labelled content
• GLOW Skin contains GHK-Cu, BPC-157 & TB-500
• Retatrutide formulation
• Pen-format research products
• 12 disposable needles included with each product according to packaging
• Instruction book included with each product

How to Use (Research Reference Only)

These products are intended exclusively for laboratory and scientific research conducted by qualified professionals using appropriate research protocols.

Experimental handling, preparation, storage, and application should follow relevant laboratory procedures and institutional requirements.

Not intended for human consumption or self-administration.

Research Applications

The individual formulations may be investigated in research involving:

• Metabolic signalling
• GLP-1, GIP and glucagon receptor pathways
• Peptide-receptor interactions
• Cellular signalling
• Tissue biology
• Molecular and biochemical pathways
• Multi-component peptide research

Research Disclaimer

For laboratory and scientific research use only. ( Synedica Retatrutide 40mg + GLOW Skin 112mg Bundle )

Not intended for human consumption, therapeutic use, diagnosis, treatment, or prevention of disease.

What is Included in the Synedica Retatrutide 40mg + GLOW Skin 112mg Bundle?

The Synedica bundle combines a 40mg Retatrutide Pen with a 112mg GLOW Skin Pen. The GLOW Skin formulation contains 80mg GHK-Cu, 16mg BPC-157 and 16mg TB-500, providing 152mg of combined labelled content across the two products.